Reply for "Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy"

Noemi Lois, Vikki McBain, Ehab Abdelkader, Neil W. Scott, Reena Kumari

Research output: Contribution to journalLetter

Abstract

We would like to thank Dr. Rubowitz for his interest in our article entitled “Retinal pigment epithelial (RPE) atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor (VEGF) therapy,” published in a very recent issue of Retina.1 We first described and presented the frequent occurrence of RPE atrophy, determined by fundus autofluorescence and near infrared autofluorescence, and its possible relationship with VEGF blockage at the Thirty-Fourth Annual Meeting of the Macula Society in March 2011. This observation followed on our previous work identifying very high rates of RPE atrophy in patients with retinal angiomatous proliferation undergoing, mostly, anti-VEGF treatment.2
Original languageEnglish
Pages (from-to)1998-1999
Number of pages2
JournalRetina
Volume33
Issue number9
DOIs
Publication statusPublished - Oct 2013

    Fingerprint

ASJC Scopus subject areas

  • Ophthalmology

Cite this